Annual CFF
$33.00 M
$0.000.00%
31 December 2023
Summary:
Arcus Biosciences annual cash flow from financing activities is currently $33.00 million, unchanged on 31 December 2023. During the last 3 years, it has fallen by -$406.00 million (-92.48%). RCUS annual CFF is now -92.48% below its all-time high of $439.00 million, reached on 31 December 2020.RCUS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$48.00 M
+$46.00 M+2300.00%
30 September 2024
Summary:
Arcus Biosciences quarterly cash flow from financing activities is currently $48.00 million, with the most recent change of +$46.00 million (+2300.00%) on 30 September 2024. Over the past year, it has increased by +$42.00 million (+700.00%). RCUS quarterly CFF is now -85.40% below its all-time high of $328.87 million, reached on 30 June 2020.RCUS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$282.00 M
+$42.00 M+17.50%
30 September 2024
Summary:
Arcus Biosciences TTM cash flow from financing activities is currently $282.00 million, with the most recent change of +$42.00 million (+17.50%) on 30 September 2024. Over the past year, it has increased by +$241.00 million (+587.80%). RCUS TTM CFF is now -57.31% below its all-time high of $660.51 million, reached on 31 March 2021.RCUS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | +700.0% | +587.8% |
| 3 y3 years | -92.5% | +3541.9% | +23.9% |
| 5 y5 years | -74.4% | +10000.0% | +10000.0% |
RCUS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.5% | at low | -79.0% | +4700.0% | at high | +1384.2% |
| 5 y | 5 years | -92.5% | +2838.6% | -85.4% | >+9999.0% | -57.3% | >+9999.0% |
| alltime | all time | -92.5% | +2838.6% | -85.4% | +4393.4% | -57.3% | >+9999.0% |
Arcus Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $48.00 M(+2300.0%) | $282.00 M(+17.5%) |
| June 2024 | - | $2.00 M(-99.1%) | $240.00 M(-8.0%) |
| Mar 2024 | - | $229.00 M(+7533.3%) | $261.00 M(+690.9%) |
| Dec 2023 | $33.00 M(0.0%) | $3.00 M(-50.0%) | $33.00 M(-19.5%) |
| Sept 2023 | - | $6.00 M(-73.9%) | $41.00 M(+7.9%) |
| June 2023 | - | $23.00 M(+2200.0%) | $38.00 M(+100.0%) |
| Mar 2023 | - | $1.00 M(-90.9%) | $19.00 M(-42.4%) |
| Dec 2022 | $33.00 M(-86.1%) | $11.00 M(+266.7%) | $33.00 M(-1.0%) |
| Sept 2022 | - | $3.00 M(-25.0%) | $33.33 M(+5.3%) |
| June 2022 | - | $4.00 M(-73.3%) | $31.65 M(+5.9%) |
| Mar 2022 | - | $15.00 M(+32.4%) | $29.88 M(-87.4%) |
| Dec 2021 | $237.00 M(-46.0%) | $11.33 M(+759.7%) | $237.00 M(+4.1%) |
| Sept 2021 | - | $1.32 M(-40.9%) | $227.67 M(-31.8%) |
| June 2021 | - | $2.23 M(-99.0%) | $333.87 M(-49.5%) |
| Mar 2021 | - | $222.12 M(>+9900.0%) | $660.51 M(+50.5%) |
| Dec 2020 | $439.00 M | $2.00 M(-98.1%) | $439.00 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $107.52 M(-67.3%) | $437.52 M(+32.6%) |
| June 2020 | - | $328.87 M(>+9900.0%) | $329.96 M(>+9900.0%) |
| Mar 2020 | - | $610.00 K(+17.3%) | $1.74 M(+54.8%) |
| Dec 2019 | $1.12 M(-99.1%) | $520.00 K(-1368.3%) | $1.12 M(-18.3%) |
| Sept 2019 | - | -$41.00 K(-106.3%) | $1.37 M(-2.4%) |
| June 2019 | - | $649.00 K(<-9900.0%) | $1.41 M(-492.2%) |
| Mar 2019 | - | -$5000.00(-100.6%) | -$359.00 K(-100.3%) |
| Dec 2018 | $129.07 M(+20.2%) | $771.00 K(<-9900.0%) | $129.07 M(-45.1%) |
| Sept 2018 | - | -$7000.00(-99.4%) | $234.90 M(-0.1%) |
| June 2018 | - | -$1.12 M(-100.9%) | $235.10 M(-0.7%) |
| Mar 2018 | - | $129.43 M(+21.4%) | $236.79 M(+120.5%) |
| Dec 2017 | $107.40 M(+53.2%) | $106.60 M(>+9900.0%) | $107.40 M(>+9900.0%) |
| Sept 2017 | - | $189.00 K(-67.4%) | $797.00 K(+31.1%) |
| June 2017 | - | $579.00 K(+1896.6%) | $608.00 K(+1996.6%) |
| Mar 2017 | - | $29.00 K | $29.00 K |
| Dec 2016 | $70.10 M | - | - |
FAQ
- What is Arcus Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Arcus Biosciences?
- What is Arcus Biosciences annual CFF year-on-year change?
- What is Arcus Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Arcus Biosciences?
- What is Arcus Biosciences quarterly CFF year-on-year change?
- What is Arcus Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Arcus Biosciences?
- What is Arcus Biosciences TTM CFF year-on-year change?
What is Arcus Biosciences annual cash flow from financing activities?
The current annual CFF of RCUS is $33.00 M
What is the all time high annual CFF for Arcus Biosciences?
Arcus Biosciences all-time high annual cash flow from financing activities is $439.00 M
What is Arcus Biosciences annual CFF year-on-year change?
Over the past year, RCUS annual cash flow from financing activities has changed by $0.00 (0.00%)
What is Arcus Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of RCUS is $48.00 M
What is the all time high quarterly CFF for Arcus Biosciences?
Arcus Biosciences all-time high quarterly cash flow from financing activities is $328.87 M
What is Arcus Biosciences quarterly CFF year-on-year change?
Over the past year, RCUS quarterly cash flow from financing activities has changed by +$42.00 M (+700.00%)
What is Arcus Biosciences TTM cash flow from financing activities?
The current TTM CFF of RCUS is $282.00 M
What is the all time high TTM CFF for Arcus Biosciences?
Arcus Biosciences all-time high TTM cash flow from financing activities is $660.51 M
What is Arcus Biosciences TTM CFF year-on-year change?
Over the past year, RCUS TTM cash flow from financing activities has changed by +$241.00 M (+587.80%)